4//SEC Filing
Saks Samuel R 4
Accession 0001209191-19-015930
CIK 0001377121other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:32 PM ET
Size
10.5 KB
Accession
0001209191-19-015930
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Common Stock
2019-02-28+2,500→ 2,500 total - Award
Stock Option (right to buy)
2019-02-28+15,000→ 15,000 totalExercise: $8.02Exp: 2029-02-27→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date.
- [F2]The stock option vests in 48 equal monthly installments following the date of grant.
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001365615
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:32 PM ET
- Size
- 10.5 KB